Literature DB >> 19533366

Limited utility of name-based tuberculosis contact investigations among persons using illicit drugs: results of an outbreak investigation.

Rana Jawad Asghar1, David E Patlan, Mark C Miner, Halsey D Rhodes, Anthony Solages, Dolly J Katz, David S Beall, Kashef Ijaz, John E Oeltmann.   

Abstract

Persons named by a patient with tuberculosis (TB) are the focus of traditional TB contact investigations. However, patients who use illicit drugs are often reluctant to name contacts. Between January 2004 and May 2005, 18 isoniazid-resistant TB cases with matching Mycobacterium tuberculosis genotypes (spoligotypes) were reported in Miami; most patients frequented crack houses and did not name potentially infected contacts. We reviewed medical records and re-interviewed patients about contacts and locations frequented to describe transmission patterns and make recommendations to control TB in this population. Observed contacts were not named but were encountered at the same crack houses as the patients. Contacts were evaluated for latent TB infection with a tuberculosis skin test (TST). All 18 patients had pulmonary TB. Twelve (67%) reported crack use and 14 (78%) any illicit drug use. Of the 187 contacts evaluated, 91 (49%) were named, 16 (8%) attended a church reported by a patient, 61 (33%) used a dialysis center reported by a patient, and 19 (10%) were observed contacts at local crack houses. Compared to named contacts, observed contacts were eight times as likely to have positive TST results (relative risk = 7.8; 95% confidence interval = 3.8-16.1). Dialysis center and church contacts had no elevated risk of a positive TST result. Testing observed contacts may provide a higher yield than traditional name-based contact investigations for tuberculosis patients who use illicit drugs or frequent venues characterized by illicit drug use.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19533366      PMCID: PMC2729866          DOI: 10.1007/s11524-009-9378-z

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  10 in total

1.  Evaluation of tuberculosis contact investigations in California.

Authors:  J E Sprinson; J Flood; C S Fan; T A Shaw; L Pascopella; J A Young; S E Royce
Journal:  Int J Tuberc Lung Dis       Date:  2003-12       Impact factor: 2.373

2.  Tuberculosis contact investigations.

Authors:  Mary R Reichler; Sue Etkind; Zachary Taylor; Kenneth G Castro
Journal:  Int J Tuberc Lung Dis       Date:  2003-12       Impact factor: 2.373

3.  Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection.

Authors:  Naile Malakmadze; Idalia M González; Tanya Oemig; Ijeoma Isiadinso; Desiree Rembert; Mary M McCauley; Philip Wand; Lois Diem; Lauren Cowan; Gabriel J Palumbo; Michael Fraser; Kashef Ijaz
Journal:  Clin Infect Dis       Date:  2005-01-07       Impact factor: 9.079

4.  A preventable outbreak of tuberculosis investigated through an intricate social network.

Authors:  L K Fitzpatrick; J A Hardacker; W Heirendt; T Agerton; A Streicher; H Melnyk; R Ridzon; S Valway; I Onorato
Journal:  Clin Infect Dis       Date:  2001-10-24       Impact factor: 9.079

5.  Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2005-12-16

Review 6.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

7.  Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999.

Authors:  J Jereb; S C Etkind; O T Joglar; M Moore; Z Taylor
Journal:  Int J Tuberc Lung Dis       Date:  2003-12       Impact factor: 2.373

8.  Drug dependence, a possible new risk factor for tuberculosis disease.

Authors:  L B Reichman; C P Felton; J R Edsall
Journal:  Arch Intern Med       Date:  1979-03

9.  Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004.

Authors:  John E Oeltmann; Eyal Oren; Maryam B Haddad; Linda k Lake; Theresa A Harrington; Kashef Ijaz; Masahiro Narita
Journal:  Emerg Infect Dis       Date:  2006-07       Impact factor: 6.883

10.  Crack cocaine and infectious tuberculosis.

Authors:  Alistair Story; Graham Bothamley; Andrew Hayward
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

  10 in total
  16 in total

1.  Collection of social determinant of health measures in U.S. national surveillance systems for HIV, viral hepatitis, STDs, and TB.

Authors:  Victoria M Beltran; Kathleen McDavid Harrison; H Irene Hall; Hazel D Dean
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

2.  A tuberculosis outbreak fueled by cross-border travel and illicit substances: Nevada and Arizona.

Authors:  Kiren Mitruka; Haley Blake; Philip Ricks; Roque Miramontes; Sapna Bamrah; Carla Chee; Laurie Hickstein
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

3.  Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis.

Authors:  T A Thomas; S K Heysell; E R Houpt; J L Moore; S J Keller
Journal:  Int J Tuberc Lung Dis       Date:  2014-05       Impact factor: 2.373

4.  Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing.

Authors:  David Stucki; Marie Ballif; Thomas Bodmer; Mireia Coscolla; Anne-Marie Maurer; Sara Droz; Christa Butz; Sonia Borrell; Christel Längle; Julia Feldmann; Hansjakob Furrer; Carlo Mordasini; Peter Helbling; Hans L Rieder; Matthias Egger; Sébastien Gagneux; Lukas Fenner
Journal:  J Infect Dis       Date:  2014-10-30       Impact factor: 5.226

5.  COVID-19 Case Investigation and Contact Tracing in the US, 2020.

Authors:  R Ryan Lash; Patrick K Moonan; Brittany L Byers; Robert A Bonacci; Kimberly E Bonner; Matthew Donahue; Catherine V Donovan; Heather N Grome; Julia M Janssen; Reed Magleby; Heather P McLaughlin; James S Miller; Caroline Q Pratt; Jonathan Steinberg; Kate Varela; Greta L Anschuetz; Paul R Cieslak; Veronica Fialkowski; Aaron T Fleischauer; Clay Goddard; Sara Jo Johnson; Michelle Morris; Jill Moses; Allison Newman; Lauren Prinzing; Alana C Sulka; Puthiery Va; Matthew Willis; John E Oeltmann
Journal:  JAMA Netw Open       Date:  2021-06-01

6.  Using genotyping and geospatial scanning to estimate recent mycobacterium tuberculosis transmission, United States.

Authors:  Patrick K Moonan; Smita Ghosh; John E Oeltmann; J Steven Kammerer; Lauren S Cowan; Thomas R Navin
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

Review 7.  Contact investigation for tuberculosis: a systematic review and meta-analysis.

Authors:  Gregory J Fox; Simone E Barry; Warwick J Britton; Guy B Marks
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

8.  Modern contact investigation methods for enhancing tuberculosis control in aboriginal communities.

Authors:  Victoria J Cook; Lena Shah; Jennifer Gardy
Journal:  Int J Circumpolar Health       Date:  2012-05-25       Impact factor: 1.228

9.  Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009.

Authors:  Bianca R Perri; Douglas Proops; Patrick K Moonan; Sonal S Munsiff; Barry N Kreiswirth; Natalia Kurepina; Christopher Goranson; Shama D Ahuja
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

Review 10.  Tuberculosis outbreak investigations in the United States, 2002-2008.

Authors:  Kiren Mitruka; John E Oeltmann; Kashef Ijaz; Maryam B Haddad
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.